Evaluation of Antibody Properties and Clinically Relevant Immunogenicity, Anaphylaxis, and Hypersensitivity Reactions in Two Phase III Trials of Tralokinumab in Severe, Uncontrolled Asthma.
Drug Saf
; 42(6): 769-784, 2019 06.
Article
in En
| MEDLINE
| ID: mdl-30649752
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Asthma
/
Drug Hypersensitivity
/
Anaphylaxis
/
Antibodies, Monoclonal
/
Antibody Formation
Type of study:
Clinical_trials
Limits:
Adolescent
/
Adult
/
Aged
/
Child
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Drug Saf
Journal subject:
TERAPIA POR MEDICAMENTOS
/
TOXICOLOGIA
Year:
2019
Document type:
Article
Affiliation country:
Sweden
Country of publication:
New Zealand